PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)

Mise à jour : Il y a 4 ans
Référence : NCT00867815

Extrait

The primary objective of this study is to determine whether the use of PDE5 inhibitors (vardenafil, sildenafil, or tadalafil) increases the risk for the development of NAION.


Critère d'inclusion

  • Anterior Ischemic Optic Neuropathy


Liens